Home/Emmyon/Christopher M. Adams, MD, PhD
CM

Christopher M. Adams, MD, PhD

Founder, President & CEO

Emmyon

Emmyon Pipeline

DrugIndicationPhase
URSOLYX™ Soft ChewsCanine & Feline Muscle Health/MobilityCommercial
Small Molecule TherapeuticsCancer-Induced Muscle Atrophy (Cachexia)Pre-clinical
Feed AdditivesLivestock Muscle & Metabolic HealthResearch